SMS Pharmaceuticals Ltd - 532815 - Announcement Under Regulation 30
SMS Pharmaceuticals Board of Directors approved the Q1 FY27 unaudited financial results. Key resolutions included the re-appointment of Mr. Ramesh Babu Potluri as Chairman and MD for five years and a Rs.50 crore loan to its subsidiary, SMS Peptides Private Limited, both pending shareholder approval. The 38th AGM is set for September 23, 2026, with September 16, 2026, as the record date for the FY26 dividend.
Jul 31 2026 18:05:24
SMS Pharmaceuticals Ltd - 532815 - Fixation Of Record Date
SMS Pharmaceuticals has set September 16, 2026, as the Record Date for determining eligibility for the FY2025-26 dividend. Payment is contingent on shareholder approval at the upcoming Annual General Meeting.
Jul 31 2026 17:35:30
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Management
SMS Pharmaceuticals has re-appointed Mr. Ramesh Babu Potluri as the Chairman and Managing Director for a new term of 5 years, effective from October 1, 2026, until September 30, 2031. This re-appointment is subject to the approval of the company's shareholders at the upcoming general meeting.
Jul 31 2026 17:31:28
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
SMS Pharmaceuticals board approved Q1 FY27 cons. financial results, with revenue of ₹206.96 cr (up 5.57% YoY) and net profit of ₹20.20 cr (up 7.94% YoY). The board also re-appointed Mr. Ramesh Babu Potluri as Chairman & MD for a five-year term and sanctioned a ₹50 cr loan to subsidiary SMS Peptides Private Limited for business.
Jul 31 2026 17:13:18
SMS Pharmaceuticals Ltd - 532815 - Update on board meeting
SMS Pharmaceuticals rescheduled its Board meeting to July 31, 2026, to consider Q1 FY27 unaudited financial results. The meeting was originally set for August 1, 2026.
Jul 29 2026 12:25:08
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026
SMS Pharmaceuticals' Board is scheduled to meet on August 1, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ending June 30, 2026.
Jul 25 2026 15:39:13
SMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
SMS Pharmaceuticals Ltd disclosed that police authorities arrested one person on July 19, 2026, related to an ongoing investigation into claiming shares through impersonation. The matter is currently under further investigation.
Jul 20 2026 17:10:19
Read More